We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02595866
Brief Title: Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

First Submitted : November 3, 2015
First Submitted that Met QC Criteria : November 3, 2015
First Posted : November 4, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : December 24, 2022
Last Update Posted : December 28, 2022